kinase-targeting compounds (Bayer Schering)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namekinase-targeting compounds (Bayer Schering)
Drug Alias Namekinase-targeting compounds (Nycomed)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases modulators
TargetsProtein kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A